We are living in a ‘smart’ generation, and our daily lives are being transformed by new technologies. In contrast to electronics such as smartphones and smart televisions, biotechnologies using smart materials such as at-home diagnostics, personalized medications, and early disease detection remain a challenge. We bridge this gap between innovation and fundamental science by developing next-generation semiconductor platforms using novel nanoscience and nanostructures.

PLUS Lab is to develop next-generation platforms utilizing semiconductor technology that generate Big Data of health-related biomolecules. These platforms provide data sources for A.I. or machine learning that open a door to ‘smart’ health care systems. To achieve the goal, we study semiconducting technology and then apply it to design proper platforms depending on the applications. Once developed, it could be used to overcome the current limitations of selective and sensitive biomolecular recognition (such as ultrafast and sensitive COVID-19 detection), imaging, and analysis.